Symbols / UNCY Stock $7.71 +6.93% Unicycive Therapeutics, Inc.
UNCY (Stock) Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Market Cap | 194.58M | Enterprise Value | 153.43M | Income | -26.55M | Sales | — | Book/sh | 1.36 | Cash/sh | 1.64 |
| Dividend Yield | — | Payout | 0.00% | Employees | 21 | IPO | — | P/E | — | Forward P/E | 0.90 |
| PEG | — | P/S | — | P/B | 5.65 | P/C | — | EV/EBITDA | -5.20 | EV/Sales | — |
| Quick Ratio | 2.18 | Current Ratio | 2.58 | Debt/Eq | 0.39 | LT Debt/Eq | — | EPS (ttm) | — | EPS next Y | 8.58 |
| EPS Growth | — | Revenue Growth | — | Earnings | 2026-03-30 | ROA | -45.66% | ROE | -141.15% | ROIC | — |
| Gross Margin | 0.00% | Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | — | Shs Float | 22.82M | Short Float | 7.43% |
| Short Ratio | 4.00 | Short Interest | — | 52W High | 11.00 | 52W Low | 3.71 | Beta | 1.80 | Avg Volume | 557.36K |
| Volume | 752.06K | Target Price | $39.89 | Recom | Strong_buy | Prev Close | $7.21 | Price | $7.71 | Change | 6.93% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- Unicycive Therapeutics (UNCY) Stock: Why Profit Growth (Edges Up) 2026-04-20 - Open Stock Signal Network - Cổng thông tin điện tử tỉnh Lào Cai Mon, 20 Apr 2026 15
- Unicycive Therapeutics (UNCY) Stock: Why Profit Growth (Edges Up) 2026-04-20 - Professional Trade Ideas - Xã Thanh Hà Mon, 20 Apr 2026 15
- UNCY Forecast, Price Target & Analyst Ratings | UNICYCIVE THERAPEUTICS INC (NASDAQ:UNCY) - ChartMill Fri, 17 Apr 2026 07
- Companies Like Unicycive Therapeutics (NASDAQ:UNCY) Are In A Position To Invest In Growth - Yahoo Finance Mon, 29 Dec 2025 08
- Unicycive CEO gets April 15 speaking slot at Needham healthcare event - Stock Titan hu, 09 Apr 2026 07
- Unicycive Therapeutics Provides Business Update and Financial Results, Poised to Resubmit NDA for Oxylanthanum Carbonate by Year-End | UNCY Stock News - Quiver Quantitative Wed, 12 Nov 2025 08
- We Might See A Profit From Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Soon - simplywall.st Mon, 12 Jan 2026 08
- UNCY Retail Buzz Explodes 150% This Week as Traders Bet Big on Experimental Drug Approval - Stocktwits Wed, 01 Apr 2026 07
- Unicycive: 'Buy' Rating On NDA Resubmission OLC And Potential Best-In-Class Profile - Seeking Alpha hu, 29 Jan 2026 08
- Unicycive readies kidney drug launch with FDA decision due June 29 - Stock Titan Mon, 30 Mar 2026 07
- When Will Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Turn A Profit? - Yahoo Finance ue, 14 Oct 2025 07
- FDA sets June 27 action date for Unicycive kidney disease pill - Stock Titan hu, 29 Jan 2026 08
- What happens to Unicycive Therapeutics (UNCY) Stock in recession | Price at $6.68, Up 0.91% - Trending Buy Opportunities - Cổng thông tin điện tử tỉnh Lào Cai ue, 07 Apr 2026 07
- Is Unicycive Therapeutics (NASDAQ:UNCY) In A Good Position To Invest In Growth? - Yahoo Finance ue, 22 Jul 2025 07
- New pill for dialysis patients moves ahead as FDA review restarts - Stock Titan Mon, 29 Dec 2025 08
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
-100.00%
|
0.68
-29.02%
|
0.95
|
| Operating Revenue |
|
0.00
|
0.00
-100.00%
|
0.68
-29.02%
|
0.95
|
| Operating Expense |
|
29.52
-8.10%
|
32.12
+49.74%
|
21.45
+12.87%
|
19.00
|
| Research And Development |
|
9.12
-54.43%
|
20.01
+55.12%
|
12.90
+3.75%
|
12.44
|
| Selling General And Administration |
|
20.40
+68.52%
|
12.10
+41.61%
|
8.55
+30.15%
|
6.57
|
| General And Administrative Expense |
|
20.40
+68.52%
|
12.10
+41.61%
|
8.55
+30.15%
|
6.57
|
| Other Gand A |
|
20.40
+68.52%
|
12.10
+41.61%
|
8.55
+30.15%
|
6.57
|
| Total Expenses |
|
29.52
-8.10%
|
32.12
+49.74%
|
21.45
+12.87%
|
19.00
|
| Operating Income |
|
-29.52
+8.10%
|
-32.12
-54.60%
|
-20.77
-15.08%
|
-18.05
|
| Total Operating Income As Reported |
|
-29.52
+8.10%
|
-32.12
-54.60%
|
-20.77
-15.08%
|
-18.05
|
| EBITDA |
|
-25.91
+28.48%
|
-36.23
-20.05%
|
-30.18
-68.68%
|
-17.89
|
| Normalized EBITDA |
|
-27.93
+8.20%
|
-30.43
-53.10%
|
-19.88
-11.09%
|
-17.89
|
| Reconciled Depreciation |
|
0.57
+33.64%
|
0.43
+50.70%
|
0.28
+76.40%
|
0.16
|
| EBIT |
|
-26.48
+27.75%
|
-36.66
-20.34%
|
-30.46
-68.75%
|
-18.05
|
| Total Unusual Items |
|
2.02
+134.83%
|
-5.80
+43.69%
|
-10.30
|
0.00
|
| Total Unusual Items Excluding Goodwill |
|
2.02
+134.83%
|
-5.80
+43.69%
|
-10.30
|
0.00
|
| Special Income Charges |
|
—
|
—
|
—
|
0.00
|
| Other Special Charges |
|
—
|
—
|
—
|
—
|
| Net Income |
|
-26.55
+27.70%
|
-36.73
-20.25%
|
-30.54
-69.14%
|
-18.06
|
| Pretax Income |
|
-26.55
+27.70%
|
-36.73
-20.25%
|
-30.54
-69.14%
|
-18.06
|
| Net Non Operating Interest Income Expense |
|
0.94
-20.92%
|
1.19
+123.26%
|
0.53
+8983.33%
|
-0.01
|
| Interest Expense Non Operating |
|
0.07
+0.00%
|
0.07
-13.41%
|
0.08
+1266.67%
|
0.01
|
| Net Interest Income |
|
0.94
-20.92%
|
1.19
+123.26%
|
0.53
+8983.33%
|
-0.01
|
| Interest Expense |
|
0.07
+0.00%
|
0.07
-13.41%
|
0.08
+1266.67%
|
0.01
|
| Interest Income Non Operating |
|
1.01
-19.75%
|
1.26
+105.04%
|
0.61
|
0.00
|
| Interest Income |
|
1.01
-19.75%
|
1.26
+105.04%
|
0.61
|
0.00
|
| Other Income Expense |
|
2.02
+134.83%
|
-5.80
+43.69%
|
-10.30
|
—
|
| Gain On Sale Of Security |
|
2.02
+134.83%
|
-5.80
+43.69%
|
-10.30
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-26.55
+27.70%
|
-36.73
-20.25%
|
-30.54
-69.14%
|
-18.06
|
| Net Income From Continuing Operation Net Minority Interest |
|
-26.55
+27.70%
|
-36.73
-20.25%
|
-30.54
-69.14%
|
-18.06
|
| Net Income From Continuing And Discontinued Operation |
|
-26.55
+27.70%
|
-36.73
-20.25%
|
-30.54
-69.14%
|
-18.06
|
| Net Income Continuous Operations |
|
-26.55
+27.70%
|
-36.73
-20.25%
|
-30.54
-69.14%
|
-18.06
|
| Normalized Income |
|
-28.58
+7.60%
|
-30.93
-52.79%
|
-20.24
-12.09%
|
-18.06
|
| Net Income Common Stockholders |
|
-26.55
+29.79%
|
-37.82
-20.42%
|
-31.41
-73.95%
|
-18.06
|
| Diluted EPS |
|
—
|
-5.65
+55.86%
|
-12.80
-6.67%
|
-12.00
|
| Basic EPS |
|
—
|
-5.65
+55.86%
|
-12.80
-6.67%
|
-12.00
|
| Basic Average Shares |
|
—
|
6.70
+172.97%
|
2.45
+62.98%
|
1.51
|
| Diluted Average Shares |
|
—
|
6.70
+172.97%
|
2.45
+62.98%
|
1.51
|
| Diluted NI Availto Com Stockholders |
|
-26.55
+29.79%
|
-37.82
-20.42%
|
-31.41
-73.95%
|
-18.06
|
| Preferred Stock Dividends |
|
—
|
1.09
+26.30%
|
0.87
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
49.13
+55.16%
|
31.67
+123.16%
|
14.19
+403.58%
|
2.82
|
| Current Assets |
|
48.96
+58.20%
|
30.95
+130.97%
|
13.40
+406.77%
|
2.64
|
| Cash Cash Equivalents And Short Term Investments |
|
41.27
+57.86%
|
26.14
+169.48%
|
9.70
+2032.09%
|
0.46
|
| Cash And Cash Equivalents |
|
29.20
+11.69%
|
26.14
+169.48%
|
9.70
+2032.09%
|
0.46
|
| Cash Financial |
|
29.20
+11.69%
|
26.14
+169.48%
|
9.70
+2032.09%
|
0.46
|
| Other Short Term Investments |
|
12.07
|
0.00
|
—
|
—
|
| Prepaid Assets |
|
6.52
+68.63%
|
3.87
+14.65%
|
3.37
+66.16%
|
2.03
|
| Current Deferred Assets |
|
—
|
—
|
—
|
—
|
| Other Current Assets |
|
1.17
+24.71%
|
0.94
+188.92%
|
0.33
+104.40%
|
0.16
|
| Total Non Current Assets |
|
0.17
-75.83%
|
0.72
-9.09%
|
0.79
+355.17%
|
0.17
|
| Net PPE |
|
0.17
-75.83%
|
0.72
-9.09%
|
0.79
+355.17%
|
0.17
|
| Gross PPE |
|
0.25
-67.59%
|
0.76
-6.06%
|
0.81
+346.41%
|
0.18
|
| Accumulated Depreciation |
|
-0.07
-84.62%
|
-0.04
-143.75%
|
-0.02
-128.57%
|
-0.01
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Buildings And Improvements |
|
0.11
-83.26%
|
0.65
-15.80%
|
0.77
+403.95%
|
0.15
|
| Machinery Furniture Equipment |
|
0.05
+20.51%
|
0.04
+85.71%
|
0.02
+50.00%
|
0.01
|
| Construction In Progress |
|
—
|
0.01
|
0.00
|
—
|
| Other Properties |
|
0.03
+0.00%
|
0.03
|
—
|
—
|
| Leases |
|
0.07
+32.65%
|
0.05
+133.33%
|
0.02
+40.00%
|
0.01
|
| Total Liabilities Net Minority Interest |
|
18.94
-21.86%
|
24.24
+34.65%
|
18.00
+448.11%
|
3.28
|
| Current Liabilities |
|
18.94
-21.48%
|
24.12
+37.56%
|
17.53
+433.92%
|
3.28
|
| Payables And Accrued Expenses |
|
1.82
-59.72%
|
4.53
+11.66%
|
4.05
+31.53%
|
3.08
|
| Payables |
|
0.30
-68.84%
|
0.97
+17.66%
|
0.82
-2.96%
|
0.85
|
| Accounts Payable |
|
0.30
-68.84%
|
0.97
+17.66%
|
0.82
-2.96%
|
0.85
|
| Current Accrued Expenses |
|
1.52
-57.24%
|
3.56
+10.14%
|
3.23
+44.57%
|
2.24
|
| Current Debt And Capital Lease Obligation |
|
0.20
-69.66%
|
0.66
+90.14%
|
0.34
+71.64%
|
0.20
|
| Current Debt |
|
0.08
-10.87%
|
0.09
+411.11%
|
0.02
-60.87%
|
0.05
|
| Current Capital Lease Obligation |
|
0.12
-79.26%
|
0.56
+72.48%
|
0.33
+110.97%
|
0.15
|
| Other Current Liabilities |
|
16.91
-10.67%
|
18.94
+44.18%
|
13.13
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
-100.00%
|
0.12
-74.89%
|
0.47
|
0.00
|
| Long Term Debt And Capital Lease Obligation |
|
0.00
-100.00%
|
0.12
-74.89%
|
0.47
|
0.00
|
| Long Term Capital Lease Obligation |
|
0.00
-100.00%
|
0.12
-74.89%
|
0.47
|
0.00
|
| Stockholders Equity |
|
30.20
+306.37%
|
7.43
+295.09%
|
-3.81
-717.38%
|
-0.47
|
| Common Stock Equity |
|
30.20
+306.37%
|
7.43
+295.09%
|
-3.81
-717.38%
|
-0.47
|
| Capital Stock |
|
0.02
+100.00%
|
0.01
-68.57%
|
0.04
+133.33%
|
0.01
|
| Common Stock |
|
0.02
+100.00%
|
0.01
-68.57%
|
0.04
+133.33%
|
0.01
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
22.11
+94.25%
|
11.38
+227.55%
|
3.48
+128.18%
|
1.52
|
| Ordinary Shares Number |
|
22.11
+94.25%
|
11.38
+227.55%
|
3.48
+128.18%
|
1.52
|
| Additional Paid In Capital |
|
158.00
+45.37%
|
108.69
+79.07%
|
60.70
+81.10%
|
33.52
|
| Retained Earnings |
|
-127.83
-26.22%
|
-101.27
-56.91%
|
-64.54
-89.84%
|
-34.00
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.00
|
0.00
|
—
|
—
|
| Other Equity Adjustments |
|
-0.00
|
—
|
—
|
—
|
| Total Equity Gross Minority Interest |
|
30.20
+306.37%
|
7.43
+295.09%
|
-3.81
-717.38%
|
-0.47
|
| Total Capitalization |
|
30.20
+306.37%
|
7.43
+295.09%
|
-3.81
-717.38%
|
-0.47
|
| Working Capital |
|
30.02
+339.70%
|
6.83
+265.13%
|
-4.13
-546.09%
|
-0.64
|
| Invested Capital |
|
30.28
+302.49%
|
7.52
+298.44%
|
-3.79
-802.62%
|
-0.42
|
| Total Debt |
|
0.20
-74.26%
|
0.77
-4.69%
|
0.81
+303.48%
|
0.20
|
| Capital Lease Obligations |
|
0.12
-82.82%
|
0.68
-14.12%
|
0.79
+411.61%
|
0.15
|
| Net Tangible Assets |
|
30.20
+306.37%
|
7.43
+295.09%
|
-3.81
-717.38%
|
-0.47
|
| Tangible Book Value |
|
30.20
+306.37%
|
7.43
+295.09%
|
-3.81
-717.38%
|
-0.47
|
| Dueto Related Parties Current |
|
—
|
—
|
—
|
—
|
| Line Of Credit |
|
0.08
-10.87%
|
0.09
+411.11%
|
0.02
-60.87%
|
0.05
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-31.32
-9.60%
|
-28.57
-56.29%
|
-18.28
-16.82%
|
-15.65
|
| Cash Flow From Continuing Operating Activities |
|
-31.32
-9.59%
|
-28.58
-56.30%
|
-18.28
-16.82%
|
-15.65
|
| Net Income From Continuing Operations |
|
-26.55
+27.70%
|
-36.73
-20.25%
|
-30.54
-69.14%
|
-18.06
|
| Depreciation Amortization Depletion |
|
0.57
+33.64%
|
0.43
+50.70%
|
0.28
+76.40%
|
0.16
|
| Depreciation |
|
0.57
+33.64%
|
0.43
+50.70%
|
0.28
+76.40%
|
0.16
|
| Depreciation And Amortization |
|
0.57
+33.64%
|
0.43
+50.70%
|
0.28
+76.40%
|
0.16
|
| Other Non Cash Items |
|
—
|
0.00
|
—
|
0.02
|
| Pension And Employee Benefit Expense |
|
—
|
—
|
—
|
0.00
|
| Stock Based Compensation |
|
2.64
+12.38%
|
2.35
+32.99%
|
1.77
+68.77%
|
1.05
|
| Operating Gains Losses |
|
-2.02
-134.83%
|
5.80
-43.69%
|
10.30
|
—
|
| Gain Loss On Investment Securities |
|
-2.02
-134.83%
|
5.80
-43.69%
|
10.30
|
—
|
| Change In Working Capital |
|
-5.95
-1294.38%
|
-0.43
-359.14%
|
-0.09
-107.89%
|
1.18
|
| Change In Prepaid Assets |
|
-2.88
-251.71%
|
-0.82
+26.59%
|
-1.12
-1901.61%
|
0.06
|
| Change In Payables And Accrued Expense |
|
-2.50
-417.09%
|
0.79
-38.09%
|
1.28
+0.71%
|
1.27
|
| Change In Payable |
|
-2.50
-417.09%
|
0.79
-38.09%
|
1.28
+0.71%
|
1.27
|
| Change In Account Payable |
|
-2.50
-417.09%
|
0.79
-38.09%
|
1.28
+0.71%
|
1.27
|
| Change In Other Current Liabilities |
|
-0.56
-42.32%
|
-0.40
-57.54%
|
-0.25
-66.89%
|
-0.15
|
| Investing Cash Flow |
|
-12.10
-16698.61%
|
-0.07
-500.00%
|
-0.01
-500.00%
|
-0.00
|
| Cash Flow From Continuing Investing Activities |
|
-12.10
-16698.61%
|
-0.07
-500.00%
|
-0.01
-500.00%
|
-0.00
|
| Net PPE Purchase And Sale |
|
-0.02
+66.67%
|
-0.07
-500.00%
|
-0.01
-500.00%
|
-0.00
|
| Purchase Of PPE |
|
-0.02
+66.67%
|
-0.07
-500.00%
|
-0.01
-500.00%
|
-0.00
|
| Capital Expenditure |
|
-0.02
+66.67%
|
-0.07
-500.00%
|
-0.01
-500.00%
|
-0.00
|
| Net Investment Purchase And Sale |
|
-12.07
|
0.00
|
—
|
—
|
| Purchase Of Investment |
|
-12.07
|
0.00
|
—
|
—
|
| Financing Cash Flow |
|
46.47
+3.06%
|
45.09
+63.71%
|
27.54
+5947.35%
|
-0.47
|
| Cash Flow From Continuing Financing Activities |
|
46.47
+3.06%
|
45.09
+63.71%
|
27.54
+5947.35%
|
-0.47
|
| Net Issuance Payments Of Debt |
|
—
|
—
|
—
|
0.00
|
| Issuance Of Debt |
|
—
|
—
|
—
|
0.00
|
| Repayment Of Debt |
|
—
|
—
|
—
|
0.00
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Long Term Debt Payments |
|
—
|
—
|
—
|
0.00
|
| Net Long Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Net Common Stock Issuance |
|
46.58
+6720.20%
|
0.68
|
0.00
-100.00%
|
0.01
|
| Cash Dividends Paid |
|
0.00
+100.00%
|
-1.09
|
0.00
|
—
|
| Proceeds From Stock Option Exercised |
|
1.50
|
0.00
|
—
|
0.00
|
| Net Other Financing Charges |
|
-1.61
+64.22%
|
-4.50
-69.88%
|
-2.65
-449.59%
|
-0.48
|
| Changes In Cash |
|
3.06
-81.41%
|
16.44
+77.82%
|
9.25
+157.34%
|
-16.12
|
| Beginning Cash Position |
|
26.14
+169.48%
|
9.70
+2032.09%
|
0.46
-97.26%
|
16.58
|
| End Cash Position |
|
29.20
+11.69%
|
26.14
+169.48%
|
9.70
+2032.09%
|
0.46
|
| Free Cash Flow |
|
-31.34
-9.40%
|
-28.65
-56.58%
|
-18.30
-16.88%
|
-15.65
|
| Interest Paid Supplemental Data |
|
0.00
-100.00%
|
0.01
-50.00%
|
0.02
+300.00%
|
0.01
|
| Income Tax Paid Supplemental Data |
|
—
|
0.00
|
0.00
|
0.00
|
| Common Stock Issuance |
|
46.58
+6720.20%
|
0.68
|
0.00
-100.00%
|
0.01
|
| Issuance Of Capital Stock |
|
46.58
-8.09%
|
50.68
+67.88%
|
30.19
+274354.55%
|
0.01
|
| Net Preferred Stock Issuance |
|
0.00
-100.00%
|
50.00
+65.62%
|
30.19
|
0.00
|
| Preferred Stock Issuance |
|
0.00
-100.00%
|
50.00
+65.62%
|
30.19
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-06 View
- 8-K2026-03-30 View
- 10-K2026-03-30 View
- 8-K2025-11-14 View
- 8-K2025-11-12 View
- 10-Q2025-11-12 View
- 8-K2025-10-28 View
- 42025-08-26 View
- 8-K2025-08-18 View
- 8-K2025-08-15 View
- 8-K2025-08-14 View
- 10-Q2025-08-14 View
- 42025-07-30 View
- 42025-07-30 View
- 42025-07-30 View
- 42025-07-30 View
- 42025-07-30 View
- 42025-07-30 View
- 42025-07-30 View
- 8-K2025-07-08 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|